Search Results - "Passera, R."

Next-generation sequencing and real-time quantitative PCR for minimal residual disease detection in B-cell disorders by Ladetto, M, Brüggemann, M, Monitillo, L, Ferrero, S, Pepin, F, Drandi, D, Barbero, D, Palumbo, A, Passera, R, Boccadoro, M, Ritgen, M, Gökbuget, N, Zheng, J, Carlton, V, Trautmann, H, Faham, M, Pott, C

“…In this study, we compared immunoglobulin heavy-chain-gene-based minimal residual disease (MRD) detection by real-time quantitative PCR (RQ-PCR) and…”
Get full text

Single-incision laparoscopic cholecystectomy is responsible for increased adverse events: results of a meta-analysis of randomized controlled trials by Arezzo, A., Passera, R., Forcignanò, E., Rapetti, L., Cirocchi, R., Morino, M.

“…Background Over the last decade, single-incision laparoscopic cholecystectomy (SLC) has gained popularity, although it is not evident if benefits of this…”
Get full text

Long-term results of the GIMEMA VEL-03-096 trial in MM patients receiving VTD consolidation after ASCT: MRD kinetics' impact on survival by Ferrero, S, Ladetto, M, Drandi, D, Cavallo, F, Genuardi, E, Urbano, M, Caltagirone, S, Grasso, M, Rossini, F, Guglielmelli, T, Cangialosi, C, Liberati, A M, Callea, V, Carovita, T, Crippa, C, De Rosa, L, Pisani, F, Falcone, A P, Pregno, P, Oliva, S, Terragna, C, Musto, P, Passera, R, Boccadoro, M, Palumbo, A

“…Polymerase chain reaction (PCR)-based minimal residual disease (MRD) analysis is a useful prognostic tool in multiple myeloma (MM), although its long-term…”
Get full text

Transanal Endoscopic Operation under spinal anaesthesia by Arezzo, A., Cortese, G., Arolfo, S., Bullano, A., Passera, R., Galietti, E., Morino, M.

“…Background Transanal Endoscopic Operation (TEO®) for rectal benign lesions and early rectal cancer may provide better oncological outcomes than flexible…”
Get full text

Prospective molecular monitoring of minimal residual disease after non-myeloablative allografting in newly diagnosed multiple myeloma by Ladetto, M, Ferrero, S, Drandi, D, Festuccia, M, Patriarca, F, Mordini, N, Cena, S, Benedetto, R, Guarona, G, Ferrando, F, Brunello, L, Ghione, P, Boccasavia, V, Fanin, R, Omedè, P, Giaccone, L, Palumbo, A, Passera, R, Boccadoro, M, Bruno, B

Get full text

A phase 2 study of three low-dose intensity subcutaneous bortezomib regimens in elderly frail patients with untreated multiple myeloma by Larocca, A, Bringhen, S, Petrucci, M T, Oliva, S, Falcone, A P, Caravita, T, Villani, O, Benevolo, G, Liberati, A M, Morabito, F, Montefusco, V, Passera, R, De Rosa, L, Omedé, P, Vincelli, I D, Spada, S, Carella, A M, Ponticelli, E, Derudas, D, Genuardi, M, Guglielmelli, T, Nozzoli, C, Aghemo, E, De Paoli, L, Conticello, C, Musolino, C, Offidani, M, Boccadoro, M, Sonneveld, P, Palumbo, A

“…This phase 2 trial evaluated three low-dose intensity subcutaneous bortezomib-based treatments in patients ⩾75 years with newly diagnosed multiple myeloma…”
Get full text

An Advanced Surgical Dressing for High-risk Patients Undergoing Breast Cancer Surgery: A Case-control Study by Nicotera, A., Ferrando, P.M., Ala, A., Brunetti, M., D’Anna, M.R., Passera, R., Malan, F.

“…Oncological breast surgeries, classified as breast conserving surgery, oncoplastic surgery, and mastectomies (standard or with tissue sparing and…”
Get full text

Long-term follow-up of allogeneic stem cell transplantation in relapsed/refractory Hodgkin lymphoma by Giaccone, L, Festuccia, M, Zallio, F, Sorasio, R, Brunello, L, Maffini, E, Dellacasa, C, Passera, R, Iovino, G, Aydin, S, Boccadoro, M, Vitolo, U, Mordini, N, Pini, M, Busca, A, Bruno, B

Get full text

Individual participant data pooled-analysis of risk factors for recurrence after neoadjuvant radiotherapy and transanal local excision of rectal cancer: the PARTTLE study by Arezzo, A., Lo Secco, G., Passera, R., Esposito, L., Guerrieri, M., Ortenzi, M., Bujko, K., Perez, R. O., Habr-Gama, A., Stipa, F., Picchio, M., Restivo, A., Zorcolo, L., Coco, C., Rizzo, G., Mistrangelo, M., Morino, M.

“…Background An organ-preserving strategy may be a valid alternative in the treatment of selected patients with rectal cancer after neoadjuvant radiotherapy…”
Get full text

Perineal stapled prolapse resection for full-thickness external rectal prolapse: a multicentre prospective study by Mistrangelo, M., Tonello, P., Brachet Contul, R., Arnone, G., Passera, R., Grasso, L., Rapetti, L., Borroni, R., Pozzo, M., Roveroni, M., Morino, M., Perinotti, R.

“…Aim Many different surgical techniques have been reported for the surgical treatment of full‐thickness external rectal prolapse. Perianal stapled prolapse…”
Get full text

Bone marrow disease detection with FDG-PET/CT and bone marrow biopsy during the staging of malignant lymphoma: results from a large multicentre study by Pelosi, E, Penna, D, Douroukas, A, Bellò, M, Amati, A, Arena, V, Passera, R, Bisi, G

“…To compare the accuracy of bone marrow biopsy (BMb) and positron emission tomography (PET) in bone marrow disease (BMD) detection, in a large multicentre…”
Get full text

Deep‐vein thrombosis rates after major orthopedic surgery in Asia. An epidemiological study based on postoperative screening with centrally adjudicated bilateral venography by PIOVELLA, F., WANG, C‐J., LU, H., LEE, K., LEE, L. H., LEE, W. C., TURPIE, A. G. G., GALLUS, A. S., PLANÈS, A., PASSERA, R., ROUILLON, A.

“…Background: The incidence of postsurgical venous thromboembolism is thought to be low in Asian ethnic populations. Objective: We studied the incidence of…”
Get full text

Telomere length is an independent predictor of survival, treatment requirement and Richter's syndrome transformation in chronic lymphocytic leukemia by Rossi, D, Lobetti Bodoni, C, Genuardi, E, Monitillo, L, Drandi, D, Cerri, M, Deambrogi, C, Ricca, I, Rocci, A, Ferrero, S, Bernocco, E, Capello, D, De Paoli, L, Bergui, L, Boi, M, Omedè, P, Massaia, M, Tarella, C, Passera, R, Boccadoro, M, Gaidano, G, Ladetto, M

“…Telomere length (TL) has been associated with outcome in chronic lymphocytic leukemia (CLL). The aim of this extensive analysis carried out on 401 CLL patients…”
Get full text

Radioimmunotherapy in relapsed/refractory mantle cell lymphoma patients: final results of a European MCL Network Phase II Trial by Ferrero, S, Pastore, A, Scholz, C W, Forstpointner, R, Pezzutto, A, Bergmann, L, Trümper, L, Finke, J, Keller, U, Ghione, P, Passera, R, Hiddemann, W, Weigert, O, Unterhalt, M, Dreyling, M

Get full text

HBV reactivation in pOBI is influenced by detectable viremia at baseline rather than duration of prophylaxis with lamivudine by Cavallo, F, Ghione, P, Battaglini, M, Botto, B, Caracciolo, D, Ferrero, S, Passera, R, Vitolo, U, Boccadoro, M, Marzano, A

Get full text

Stem cell mobilization in patients with newly diagnosed multiple myeloma after lenalidomide induction therapy by Cavallo, F, Bringhen, S, Milone, G, Ben-Yehuda, D, Nagler, A, Calabrese, E, Cascavilla, N, Montefusco, V, Lupo, B, Liberati, A M, Crippa, C, Rossini, F, Passera, R, Patriarca, F, Cafro, A M, Omedè, P, Carella, A M, Peccatori, J, Catalano, L, Caravita, T, Musto, P, Petrucci, M T, Boccadoro, M, Palumbo, A

“…Lenalidomide has raised concerns regarding its potential impact on the ability to collect stem cells for autologous stem cell transplantation, especially after…”
Get full text

Clinical impact of immunophenotypic remission after allogeneic hematopoietic cell transplantation in multiple myeloma by Giaccone, L, Brunello, L, Festuccia, M, Gilestro, M, Maffini, E, Ferrando, F, Talamo, E, Passera, R, Boccadoro, M, Omedè, P, Bruno, B

“…Immunophenotypic remission (IR) is a strong prognostic factor in myeloma patients. The combination of IR and conventional CR was retrospectively evaluated in…”
Get full text

P.12.21 LAPAROSCOPY FOR EXTRAPERITONEAL RECTAL CANCER REDUCES SHORT-TERM MORBIDITY. RESULTS OF A SYSTEMATIC REVIEW AND META-ANALYSIS by Arezzo, A, Passera, R, Scozzari, G, Verra, M, Morino, M

Get full text

P.11.24 IS SINGLE-PORT LAPAROSCOPIC CHOLECYSTECTOMY SAFE? RESULTS OF A SYSTEMATIC REVIEW AND META-ANALYSIS by Arezzo, A, Scozzari, G, Famiglietti, F, Passera, R, Morino, M

Get full text

[-2]proPSA versus ultrasensitive PSA fluctuations over time in the first year from radical prostatectomy, in an high-risk prostate cancer population: A first report by De Luca, S, Passera, R, Sottile, A, Fiori, C, Scarpa, R M, Porpiglia, F

“…[-2]proPSA and its derivatives have an higher diagnostic accuracy than PSA in predicting prostate cancer (PCa). In alternative to PSA, ultrasensitive PSA…”
Get full text